Privacy in Pharmacogenetics: An End-to-End Case Study of Personalized Warfarin Dosing.
- Journal
- PubMed
In The Last Decade
doi.org/w82345079 →Countries where authors are citing Privacy in Pharmacogenetics: An End-to-End Case Study of Personalized Warfarin Dosing.
This map shows the geographic impact of Privacy in Pharmacogenetics: An End-to-End Case Study of Personalized Warfarin Dosing.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Privacy in Pharmacogenetics: An End-to-End Case Study of Personalized Warfarin Dosing. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Privacy in Pharmacogenetics: An End-to-End Case Study of Personalized Warfarin Dosing. more than expected).
Fields of papers citing Privacy in Pharmacogenetics: An End-to-End Case Study of Personalized Warfarin Dosing.
This network shows the impact of Privacy in Pharmacogenetics: An End-to-End Case Study of Personalized Warfarin Dosing.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Privacy in Pharmacogenetics: An End-to-End Case Study of Personalized Warfarin Dosing..
About Privacy in Pharmacogenetics: An End-to-End Case Study of Personalized Warfarin Dosing.
This paper, published in 2014, received 313 indexed citations . Written by Matt Fredrikson, Éric Lantz, Somesh Jha, Simon Lin, David Page and Thomas Ristenpart covering the research area of Statistics and Probability, Pharmacology and Public Health, Environmental and Occupational Health. It is primarily cited by scholars working on Artificial Intelligence (300 citations), Sociology and Political Science (33 citations) and Computer Vision and Pattern Recognition (31 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w82345079.